Jonathan Wolleben

Stock Analyst at JMP Securities

(4.51)
# 321
Out of 5,022 analysts
227
Total ratings
54.22%
Success rate
21.18%
Average return

Stocks Rated by Jonathan Wolleben

Ocular Therapeutix
Oct 1, 2025
Maintains: Market Outperform
Price Target: $20$29
Current: $11.23
Upside: +158.24%
Crinetics Pharmaceuticals
Sep 26, 2025
Maintains: Market Outperform
Price Target: $86$143
Current: $44.05
Upside: +224.63%
Rhythm Pharmaceuticals
Sep 25, 2025
Maintains: Market Outperform
Price Target: $135$142
Current: $105.20
Upside: +34.98%
KalVista Pharmaceuticals
Sep 12, 2025
Maintains: Market Outperform
Price Target: $27$28
Current: $11.54
Upside: +142.63%
Madrigal Pharmaceuticals
Aug 20, 2025
Maintains: Market Outperform
Price Target: $483$485
Current: $437.10
Upside: +10.96%
Larimar Therapeutics
Aug 19, 2025
Reiterates: Market Outperform
Price Target: $18
Current: $3.90
Upside: +361.54%
Pharvaris
Aug 13, 2025
Maintains: Market Outperform
Price Target: $55$52
Current: $20.96
Upside: +148.09%
Astria Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $25$26
Current: $11.61
Upside: +123.94%
Quince Therapeutics
Aug 12, 2025
Maintains: Market Outperform
Price Target: $9$8
Current: $1.94
Upside: +312.37%
Protagonist Therapeutics
Aug 7, 2025
Maintains: Market Outperform
Price Target: $67$69
Current: $76.94
Upside: -10.32%
Maintains: Market Outperform
Price Target: $79$81
Current: $73.28
Upside: +10.53%
Maintains: Market Outperform
Price Target: $89$87
Current: $30.13
Upside: +188.75%
Maintains: Market Outperform
Price Target: $25$15
Current: $3.97
Upside: +277.83%
Reiterates: Market Outperform
Price Target: $8
Current: $2.46
Upside: +225.20%
Reiterates: Market Outperform
Price Target: $21
Current: $15.65
Upside: +34.19%
Reiterates: Market Outperform
Price Target: $15
Current: $1.52
Upside: +886.84%
Reiterates: Market Outperform
Price Target: $19
Current: $6.16
Upside: +208.44%
Reiterates: Market Outperform
Price Target: $75
Current: $4.15
Upside: +1,709.41%
Initiates: Market Outperform
Price Target: $38
Current: $13.52
Upside: +181.07%
Reiterates: Market Outperform
Price Target: $18
Current: $6.42
Upside: +180.37%
Reiterates: Market Outperform
Price Target: $9
Current: $3.38
Upside: +166.27%
Maintains: Market Outperform
Price Target: $55$50
Current: $43.02
Upside: +16.23%
Reiterates: Market Outperform
Price Target: $90
Current: $75.73
Upside: +18.84%
Reiterates: Market Perform
Price Target: n/a
Current: $122.89
Upside: -
Downgrades: Market Perform
Price Target: $225
Current: $176.91
Upside: +27.18%
Downgrades: Accumulate
Price Target: $420$485
Current: $683.51
Upside: -29.04%
Maintains: Market Outperform
Price Target: $48$32
Current: $7.51
Upside: +326.10%
Reiterates: Market Outperform
Price Target: $8
Current: $0.53
Upside: +1,395.89%
Maintains: Outperform
Price Target: $25$24
Current: $32.58
Upside: -26.34%